Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.4.6 (
urease
)
7,490
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ureaplasma urealyticum is a causative agent ofnon-gonococcal urethritis,
prostatitis
, epididymitis and infertility. The organism is more common in partners of infertile than fertile marriages. U. urealyticum infections not only jeopardize fertility but also pose a risk for infertility treatment and resulting pregnancies. The purpose of this study was to determine the prevalence of U. urealyticum in semen of infertile and healthy men by Polymerase Chain Reaction (PCR). Semen samples were obtained from infertile patients and healthy control and were subjected to the routine andrological analysis and PCR. DNA was extracted by Cadieux method and analyzed by PCR protocol with species-specific primers for U. urealyticum (
urease
gene). U. urealyticum was detected significantly by PCR in 12 of 100 (12%) semen specimens from infertile patients and in 3 of 100 (3%) healthy men. The volume of semen fluid, concentration of sperm cells and sperm cell with normal morphology were significantly decreased in infertile men. In the group of infertile patients with PCR positive for U. urealyticum the volume, count and morphology of semen samples were lower than in the infertile patients with PCR negative results.
...
PMID:Detection of Ureaplasma urealyticum in semen of infertile men by PCR. 1909 Feb 64
Ureaplasma urealyticum is a causative agent of non-gonococcal urethritis and is implicated in the pathogenesis of
prostatitis
, epididymitis and infertility. The organism is more common in partners of infertile than fertile marriages. U. urealyticum infections not only jeopardize fertility but also pose a risk for infertility treatment and resulting pregnancies. The aim of this study was to determine the prevalence of U. urealyticum and Ureaplasma parvum in semen of infertile and healthy men by polymerase chain reaction (PCR). Semen samples were obtained from infertile patients and healthy controls and were subjected to the routine andrological analysis and PCR. DNA was extracted by the Cadieux method, and analysed by PCR protocol with specific primers for
urease
and multiple-banded antigen genes. Ureaplasmas were detected significantly by PCR in 12 of 100 (12%) semen specimens from infertile patients and in three of 100 (3%) healthy men. The volume of semen fluid, concentration of sperm cells, and sperm cell with normal morphology were significantly decreased in infertile men. In the group of infertile patients with PCR positive for Ureaplasmas, the volume, count and morphology of semen samples were lower than in the infertile patients with PCR-negative results. U. urealyticum species in semen of infertile men was found to be high (9%) than in healthy controls (1%). Detection rate for U. parvum was 3% in the infertile group and 2% in healthy men. The results indicate that U. urealyticum species is more common in specimens of infertile men. The percentage of normal sperm cells, the volume of semen and the percentage of sperm cells with motility in the PCR positive for U. urealyticum species group were lower than in the PCR positive for U. parvum group.
...
PMID:Prevalence of Ureaplasma urealyticum and Ureaplasma parvum in semen of infertile and healthy men. 1971 Mar 50
Corynebacterium urealyticum
is a well-known opportunistic uropathogen that can occur with cystitis, pyelonephritis, and urinary sepsis. Although a wide variety of coryneform bacteria have been found from the male genital tract of
prostatitis
patients, only one clinical case of
prostatitis
caused by
C. urealyticum
has been reported. The aim of this study was to evaluate the
in vitro
tropism of
C. urealyticum
towards LNCaP (lymph node carcinoma of the prostate) human cells line and the influence of acetohydroxamic acid as an irreversible
urease
inhibitor on different aspects of its pathogenicity by means of several
in vitro
tests, such as the determination and analysis of growth curves, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, the production of biofilms, and adhesion to LNCaP and HeLa cell lines. Results have brought new pieces of evidence on the
in vitro
tropism of
C. urealyticum
for the human prostate cell line LNCaP and the therapeutic use of the irreversible
urease
inhibitors such as acetohydroxamic acid (AHA), not only as enzyme blockers to facilitate the removal of encrustations but also as modulators of some pathogenic mechanisms. These interesting preliminary data allow us to assert that there is a real possibility that
C. urealyticum
is a new candidate for chronic idiopathic
prostatitis
.
...
PMID:Preliminary in Vitro Studies on
Corynebacterium urealyticum
Pathogenetic Mechanisms, a Possible Candidate for Chronic Idiopathic Prostatitis? 3221 12